Equities

Zhejiang CONBA Pharmaceutical Co Ltd

600572:SHH

Zhejiang CONBA Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)4.04
  • Today's Change-0.01 / -0.25%
  • Shares traded15.22m
  • 1 Year change-23.05%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue6,7336,0006,568
OPERATING EXPENSES
Cost of revenue total2,8362,4702,626
Selling, general and admin. expenses, total2,8212,5652,973
Depreciation/amortization130115131
Unusual expense(income)(46)1.72(1405)
Other operating expenses, total15(76)(1185)
Total operating expense5,9455,3984,034
Operating income7886022,535
Other, net(20)(12)(6.67)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes7685902,527
Provision for income taxes93130391
Net income after taxes6754602,136
Minority interest(83)(102)(118)
Net income before extra. Items5923582,017
Total extraordinary items------
Net income5923582,017
Inc.avail. to common excl. extra. Items5923582,017
Inc.avail. to common incl. extra. Items5923582,017
EPS RECONCILIATION
Basic/primary weighted average shares2,5702,5702,570
Basic/primary eps excl. extra items0.230.140.78
Basic/primary eps incl. extra items0.230.140.78
Dilution adjustment------
Diluted weighted average shares2,5702,5712,570
Diluted eps excl. extra items0.230.140.78
Diluted eps incl. extra items0.230.140.78
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.200.150.16
Gross dividend - common stock504386411
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental364973
SUPPLEMENTAL INCOME
Depreciation, supplemental296255263
Total special items(46)2.20233
NORMALISED INCOME
Normalized income before taxes7225922,760
Effect of special items on income taxes(5.55)0.4936
Income tax excluding impact of special items87130427
Normalized income after tax6344622,333
Normalized income avail. to common5513602,214
Basic normalized EPS0.210.140.86
Diluted normalized EPS0.210.140.86
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.